Drug intelligence / Profile preview

AniDes Wound Spray

Development stage: Unknown
Lead developer: Repolar Pharmaceuticals
Administration: Topical

Overview

AniDes Wound Spray is a veterinary medical device developed by Repolar Pharmaceuticals for the treatment of wounds, skin abrasions, and irritated skin in animals. The product is a topical resin-based spray formulated with active ingredients derived from Norway spruce (*Picea abies*) resin, utilizing proprietary Resol Technology. It functions by forming a protective and soothing oily film over the affected area, creating an optimal environment for wound healing and enhancing re-epithelialization. Additionally, the spray exhibits broad-spectrum antimicrobial activity against bacteria, yeasts, and fungi. It is designed to be non-stinging, alcohol-free, and contains a bittering agent to prevent animals from licking the treated site.

Brand names: AniDes Wound Spray
Other names: AniDes

Beyond the preview

Go deeper on AniDes Wound Spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AniDes Wound Spray.

Explore the full profile